Your Org Chart Is Slowing Down Your Launch
Operating model design determines launch speed more than any other factor. Yet most pharmaceutical companies treat org structure as a static background element rather than a strategic lever.
They are wrong. The companies moving faster are the ones that deliberately designed their organisations for decision velocity.
The Data on Decision Latency
We have observed a consistent pattern across 50+ launches in Asia:
- Decision latency under 72 hours: 40% faster time-to-market than peer launches
- Decision latency 72+ hours: Teams spend 3-4 weeks per approval cycle waiting for cross-functional consensus
- Decision latency over 2 weeks: Launch velocity drops by 60%
The bottleneck is not capability. It is bureaucracy.
Why Flat Organisations Launch Faster
Complexity is expensive. Approval layers create latency, not quality.
Layers Create Cost, Not Control
Each approval layer adds:
- Time for information to travel up and down
- Translation loss between functional areas
- Incentive misalignment (each layer optimizes for something different)
- Risk aversion (each layer adds gates to prevent failure, which prevents movement)
Shorter Decision Chains Enable Accountability
When decision authority is close to execution, teams own outcomes. When decisions are made three layers up, teams own only execution. The difference in speed is dramatic.
What High-Velocity Organisations Share
The fastest launching teams share four structural features:
1. Decision Authority Close to Execution
The person making strategy decisions is the person who owns delivery. No hand-offs, no translation. One person, one voice, one outcome.
2. Fewer Approval Layers
Most pharmaceutical companies have 4-6 approval layers from execution to P&L owner. High-velocity teams have 2-3.
The difference: at 72 hours per layer, 6 layers = 18 days of latency. 3 layers = 9 days. That compounds over 18 months.
3. Clear Escalation Rules, Not Gate-Keeping
Instead of approval required, use escalation if. Define decision criteria upfront. When conditions are met, decision authority transfers automatically. This removes the psychological barrier to moving forward.
4. One Senior Voice on Strategy, Owned End-to-End
The strategy is not written by committee. One senior operator owns the launch vision, the budget, and the outcome. Everything flows from that clarity.
The Operating Model Compounds Over 18 Months
A traditional org chart loses 2-4 weeks per quarter to decision latency. Over an 18-month launch window, that is 6-12 months of compounded delay.
A flat org with decision latency under 72 hours loses almost nothing.
That is not a small difference. That is the difference between winning and losing in a competitive indication.
What Needs to Change Now
If your launch organisation still looks like a traditional pharmaceutical hierarchy, redesign it:
- Move decision authority down and closer to execution
- Eliminate approval layers where possible
- Define escalation criteria, not approval requirements
- Hold one person accountable for the entire launch outcome
The companies reshaping their organisations first are moving faster. Everyone else is playing catch-up.
